Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 30;35(8):1028-1032.
doi: 10.1515/jpem-2022-0205. Print 2022 Aug 26.

Arterial hypertension is associated with an increased risk of metabolic complications in pediatric patient with obesity

Anna Stępniewska  1 , Małgorzata Wójcik  1 , Jerzy B Starzyk  1
Affiliations
Free article

Arterial hypertension is associated with an increased risk of metabolic complications in pediatric patient with obesity

Anna Stępniewska et al. J Pediatr Endocrinol Metab. .
Free article

Abstract

Objectives: Coexistence of arterial hypertension (AH) in children with obesity increases morbidity and shortens life. Its role as an indicator of coexisting metabolic complications is however less known. The objective of the study was to compare metabolic profiles of children with obesity and with or without AH.

Methods: We included patients aged 10-18 with the BMI Z-score ≥2. Diagnosis of AH was based on the European Society of Hypertension criteria (2016). Metabolic profiles were assessed by glucose and insulin levels taken before and after glucose load, fasting levels of triglycerides (TG), total (TC), low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, and HOMA-IR.

Results: Of 534 patients, 33.5% were diagnosed with AH. The AH patients, as compared to non-AH, had higher fasting insulin levels (22 vs. 19.7 mIU/L, p=0.04), HOMA-IR (4.5 vs. 4.0, p=0.029), and post-load glucose level (6.3 vs. 5.7, p=0.000041). No differences in the post-load insulin levels (113 vs. 100 mIU/L, p=0.056), fasting glucose (4.5 vs. 4.5 mmol/L, p=0.5), or lipids were found (TC: 4.4 vs. 4.4 mmol/L, p=0.9; LDL: 2.7 vs. 2.7, p=0.2; TG: 1.4 vs. 1.4 mmol/L, p=0.5; HDL: 1.1 vs. 1.2, p=0.3.

Conclusions: Concomitance of AH in children with obesity may be an indicator of coexisting metabolic complications.

Keywords: adolescent; insulin resistance; metabolic syndrome.

PubMed Disclaimer

References

    1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet 2017;390:2627–42. https://doi.org/10.1016/S0140-6736(17)32129-3.
    1. World Health Organisation. Report of the commission on ending childhood obesity. In: Implementation plan: executive summary. Geneva: World Health Organization; 2017.
    1. WHO Europe. Children Obesity Surveillance Initiative, Highlights 2015-17, Preliminary data; 2018. Available from: www.euro.who.int/__data/assets/pdf_file/0006/372426/wh14-cosi-factsheets....
    1. Fryar, CD, Carroll, MD, Afful, J. Prevalence of overweight, obesity, and severe obesity among children and adolescents aged 2–19 years: United States, 1963–1965 Through 2017–2018. Division of Health and Nutrition Examination Surveys 2018.
    1. Di Bonito, P, Licenziati, MR, Morandi, A, Maffeis, C, Miragilia del Giudice, E, Di Sessa, A, et al.. Screening for hypertension in young people with obesity: feasibility in the real life. Nutr Metabol Cardiovasc Dis 2022;32:1301–7.

LinkOut - more resources